Weekly round-up #222

Earlier today: ECR Summer Showcase Seminar Session 1

30 VALIDATE Members gathered on Zoom for the first VALIDATE ECR Summer Showcase. Dr Nguyen Ho Lam from the University of Medicine & Pharmacy, Vietnam, Dr Nidhi Gupta from the Central University of Rajasthan, India, and Dr Rachel Tanner from the University of Oxford, United Kingdom, gave short talks on their research and took questions from fellow VALIDATE members.

The next session will take place on 13 July and you can register here - www.validate-network.org/event/ecr-summer-showcase

Next week: A Vaccine for Leprosy - 28 June 2022, 16:00 BST

The third in our "A Vaccine for" seminar series will take place next Tuesday. In "A Vaccine for Leprosy?", Dr Khushboo Borah Slater and Dr Chyntia Carolina Díaz Acosta will discuss the prospects for a vaccine for Leprosy, the disease caused by Mycobacteria Leprae of which there are still over 200,000 new cases of diagnosed every year. The seminar is open to everyone (including non-members), so please spread the word. This event will be especially interesting to vaccine researchers who do not study leprosy.

Funding:

NRF DAAD Scholarship and Fellowships - MA and PhD scholarships to South African citizens and permanent South African residents for postgraduate studies at public South African universities – 30 June 2022
Justice, Equity, Diversity and Inclusion (JEDI) awards - These awards are offered to scientists from historically underrepresented races or ethnic groups and people from low socioeconomic backgrounds – Ongoing funding (deadline 10th of each month)
NIH Global Infectious Disease Research Training Program - Encourages joint applications for the Global Infectious Disease (GID) Research Training programs from the US and low- and middle-income country (LMIC) institutions – deadline 3 July 2022

You can find a list of all relevant external funding we've spotted for our members on our external funding page.

Training Opportunities and Events:

ESACT Animal Cell Technology Course 2022, 12th edition, Llafranc, Costa Brava, Spain, 18 September 2022
ESACT 2nd Bioprocessing and Manufacturing of Gene and Cell Therapy Products Course, Llafranc, Costa Brava, Spain, 25 September 2022
ESACT Discovery and Development of Novel Therapeutics Course 2022, 6th Edition, Llafranc, Costa Brava, Spain, 9 October 2022

Find more training and events opportunities on our Training and Events pages.

Job Opportunities:

AVACTA PhD studentships/First Stage Researcher (R1), Queen’s University Belfast, UK, deadline 1 July 2022

More relevant career opportunities on our jobs page.

Publications:

Estimating the contribution of subclinical tuberculosis disease to transmission – an individual patient data analysis from prevalence surveys, Emery JC et al, in MedRvix
Comment on “Multibacillary leprosy unmasked by COVID-19 vaccination”, Hanumanthu V et al, in JAAD Case Reports (original article)
Immunotherapy for visceral leishmaniasis: A trapeze of balancing counteractive forces, Priyanka H. Mazire PH et al, in International Immunopharmacology
In silico EsxG·EsxH Rational Epitope Selection: Candidate Epitopes for Vaccine, Martinez-Olivares CE et al, in bioRxiv

Check out our Publications Page for members' publications and email VALIDATE@ndm.ox.ac.uk if you have a paper you would like us to include.

Highlights on Twitter this week:

The Union opened submissions for TBScience 2022, LSE Impact had some advice for writing a conference abstract, and Stop TB Canada created an infographic about the fight against pandemics (including TB). Nature Careers offered £100 to take part in their survey of graduate students, shared a cartoon about the academic writing process and published an article on Peer to Peer career advice. Hugh Kearns shared his article on “Turbo Charging your writing, the University of Manchester shared a video about being an animal lab technician, and CEPI opened a call for submissions on research that reduces cold chain requirements. The Monitor newspaper reported on the limited progress made in fighting NTDs in Uganda, Politico covered the inequality of vaccine access, and the University of Sydney secured funding to study immune responses in TB. Keep up to date with all the relevant news and opportunities by following @NetworkVALIDATE on Twitter.

Published: 22 June 2022